Premium
Diabetes risk higher among some women who stay on antipsychotic while pregnant
Publication year - 2018
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30349
Subject(s) - ziprasidone , quetiapine , medicine , olanzapine , pregnancy , risperidone , aripiprazole , gestational diabetes , obstetrics , antipsychotic , diabetes mellitus , psychiatry , schizophrenia (object oriented programming) , gestation , endocrinology , biology , genetics
A study of pregnant women in a Medicaid database who were receiving an antipsychotic before pregnancy has found that those who continued treatment with olanzapine or quetiapine in early pregnancy had a higher risk of developing gestational diabetes than women who discontinued the medications during pregnancy. Risk of gestational diabetes was not found to be elevated with continued use of aripiprazole, ziprasidone, or risperidone in early pregnancy. Study results were published online May 7 in the American Journal of Psychiatry .